ArticleAMB Express2026
Enhanced secretion of an Agrocybe aegerita peroxygenase variant in K. phaffii using the native signal peptide.
Article in AMB Express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Unspecific Peroxygenases (UPOs) are enzymes with significant potential as catalysts in synthetic chemistry as they catalyse selective oxygenation reactions on organic substrates at the expense of only hydrogen peroxide as the external oxidant. The demand for UPOs has stimulated considerable research into efficient heterologous expression systems for their production, which have included optimisation of the signal peptide (SP) included upstream of the UPO gene. In this study we report a comparison of the production of the prototypical and widely-used UPO variant from the fungus Agrocybe aegerita (rAaeUPO-PaDa-I-H) using both its native SP and variant SPs evolved for improved heterologous expression in yeast hosts. The results show that improvements in protein production identified using variant SPs in S. cerevisiae are not necessarily extended to the yeast Komagataella phaffii. Indeed in K. phaffii we observed a five to sevenfold improvement in the activity of crude secretates produced using the native fungal SP of AaeUPO, compared with SPs that were evolved for improved expression and screened in S. cerevisiae These findings suggest that superior yields of this widely-used UPO can be obtained from scaled production in K. phaffii by using the native SP from the source fungus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.